Medexus Pharmaceuticals Inc.

MEDXF · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$23,973$5,255$13,069$10,018
Short-Term Investments$0$0$0$0
Receivables$13,306$24,030$22,381$14,407
Inventory$35,290$30,772$22,848$21,351
Other Curr. Assets$8,003$12,439$14,671$3,335
Total Curr. Assets$80,572$72,496$72,969$49,111
Property Plant & Equip (Net)$689$778$899$1,221
Goodwill$9,997$10,276$10,282$10,686
Intangibles$71,601$64,141$70,373$76,565
Long-Term Investments$0$0-$9,198$0
Tax Assets$8,979$8,042$6,806$0
Other NC Assets$0$0$9,198$1,642
Total NC Assets$91,266$83,237$88,360$90,114
Other Assets$0$0$0$0
Total Assets$171,838$155,733$161,329$139,225
Liabilities
Payables$5,730$7,750$10,158$12,046
Short-Term Debt$36,980$15,743$42,706$15,046
Tax Payable$1,368$1,318$1,183$27
Deferred Revenue$0$0$27,932$18,381
Other Curr. Liab.$53,232$41,418$29,449$20,989
Total Curr. Liab.$97,310$66,229$83,496$48,108
LT Debt$198$34,153$28,185$40,795
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$1,521
Other NC Liab.$22,187$25,028$27,200$31,009
Total NC Liab.$22,385$59,181$55,385$73,325
Other Liabilities$0$0$0$0
Cap. Leases$0$0$808$979
Total Liabilities$119,695$125,410$138,881$121,433
Equity
Pref Stock$0$0$0$0
Common Stock$96,098$76,390$69,014$68,686
Retained Earnings-$61,995-$64,242-$64,028-$65,249
AOCI$6,029$6,170$6,155$3,971
Other Equity$12,011$12,005$11,307$10,384
Total Equity$52,143$30,323$22,448$17,792
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$171,838$155,733$161,329$139,225
Net Debt$13,205$44,641$57,822$45,823
Medexus Pharmaceuticals Inc. (MEDXF) Financial Statements & Key Stats | AlphaPilot